OLIGONUKLEOTIDE MIT EINER IMMUNSYSTEMSTIMULIERENDEN SEQUENZ UND VERFAHREN ZU DEREN ANWENDUNG

European patent · EP1575977 · Deleted

Register entry

Publication number
EP1575977
Application number
EP03814325
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Dec 18, 2003
Published
Sep 21, 2005
Granted
Sep 9, 2009
Deleted
Dec 18, 2023
Reason
Maximum term reached
IPC classes
C07H 21/02 (2006.01)
C07H 21/04 (2006.01)
C07H 21/00 (2006.01)
A01N 43/04 (2006.01)
Priority
US 436122 P 23.12.2002
US 447885 P 13.02.2003
US 467546 P 01.05.2003
PCT application
PCT/US2003/041001 18.12.2003
PCT publication
WO2004/058179 15.07.2004
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Dec 18, 2023

    Maximum term reached

    Published in Swissreg on 18.12.2023

  2. Jan 9, 2023

    Change

    Published in Swissreg on 09.01.2023

  3. Mar 24, 2011

    Address changed

    Representative
    Bovard AG, Patentanwälte, Optingenstrasse 16, 3000 Bern 25 → BOVARD AG, Patent- und Markenanwälte, Optingenstrasse 16, 3000 Bern 25

    Published in Swissreg on 24.03.2011

  4. Sep 9, 2009

    Granted

    Published in Swissreg on 09.09.2009

  5. Sep 9, 2009

    Agent entered

    Representative
    Bovard AG, Patentanwälte, Optingenstrasse 16, 3000 Bern 25

    Published in Swissreg on 09.09.2009

Parties

Holder

Dynavax Technologies Corporation

2929 Seventh Street, Suite 100, Berkeley, CA 94710, US

Agent

Bovard AG

BOVARD AG

Patent- und Markenanwälte Optingenstrasse 16, 3000 Bern 25

Inventor

DINA, Dino

Oakland, CA 94618, US

FEARON, Karen, L.

Lafayette, CA 94549, US

MARSHALL, Jason

Oakland, CA 94605, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.